Across TCGA pan-cancer cohorts, RPS4XP3 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RPS4XP3 data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher RPS4XP3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS4XP3 expression acts as an unfavorable survival marker, although some lineages such as CESC and SKCM show a favorable association.
KICH, LUAD, and CESC are the cancer types where RPS4XP3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.